Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

DATE OF REPORT (Date of earliest event reported): FEBRUARY 19, 2007

000-15701

(Commission file number)

 

NATURAL ALTERNATIVES INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

 

 

Delaware   84-1007839
(State of incorporation)   (IRS Employer Identification No.)

 

1185 Linda Vista Drive

San Marcos, California 92078

   (760) 744-7340
(Address of principal executive offices)   (Registrant’s telephone number)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Item 1.01 Entry into a Material Definitive Agreement.

On February 19, 2007, the registrant’s subsidiary, Natural Alternatives International Europe S.A. (“NAIE”), entered into an amendment to its credit facility with Credit Suisse. The original loan agreement provided that the maximum aggregate amount that could be outstanding at any one time under the credit facility was CHF 1,300,000, with the maximum amount reduced by CHF 160,000 at the end of each year beginning on December 31, 2007. The amendment provides that the maximum amount will be reduced by CHF 160,000 at the end of each year but not below CHF 500,000. There are no amounts currently drawn under the credit facility.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Natural Alternatives International, Inc.
Date: February 23, 2007   By:  

/s/ John Reaves

    John Reaves
    Chief Financial Officer